MAOB and Parkinson disease: Based on the currently presented data on the effectiveness of these functional compartments, the design of such MAO-B inhibitors, containing both a xanthine cycle and hydrazide-hydrazone moiety in their structure, has become a strongly researched area to identify suitable drug candidates for the treatment of neurological diseases, particularly PD.